Current status of medical treatment for abdominal aortic aneurysm

K Kurosawa, JS Matsumura, D Yamanouchi - Circulation Journal, 2013 - jstage.jst.go.jp
2861 Medical Treatment for Abdominal Aortic Aneurysm ical treatments include anti-
hypertensives, statins, and antibiotics, some of which might work as MMP inhibitors. Tables …

Pharmacotherapy in clinical trials for abdominal aortic aneurysms: A systematic review and meta-analysis

Z Su, J Guo, Y Gu - Clinical and Applied Thrombosis …, 2022 - journals.sagepub.com
Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

Current status and perspectives on pharmacologic therapy for abdominal aortic aneurysm

K Yoshimura, N Morikage… - Current drug …, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA), a common disease involving the segmental
expansion and rupture of the aorta, has a high mortality rate. Therapeutic options for AAA …

[HTML][HTML] Medical management of abdominal aortic aneurysm

J Golledge, JT Powell - European Journal of Vascular and Endovascular …, 2007 - Elsevier
Medical management of patients with abdominal aortic aneurysm (AAA) is required for
several different reasons. Since these patients have an increased risk of cardiovascular …

Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review

R Li, Y Liu, J Jiang - International Journal of Cardiology, 2023 - Elsevier
Background Abdominal aortic aneurysms (AAA) rupture can lead to patient death. Surgical
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …

[HTML][HTML] Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction?

GM Lloyd, JD Newton, MGA Norwood… - Journal of vascular …, 2004 - Elsevier
INTRODUCTION: Antiplatelet agents, 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitors (statin drugs), angiotensin converting enzyme (ACE) inhibitors, and β-adrenergic …

Medical management of abdominal aortic aneurysms

N Weiss, RN Rodionov, A Mahlmann - Vasa, 2014 - econtent.hogrefe.com
Abdominal aortic aneurysms (AAA) are the most common arterial aneurysms. Endovascular
or open surgical aneurysm repair is indicated in patients with large AAA≥ 5.5 cm in …

[HTML][HTML] Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery

FL Moll, JT Powell, G Fraedrich, F Verzini… - European journal of …, 2011 - Elsevier
Methods Patients with AAAs are defined as male or female patients with asymptomatic,
symptomatic or ruptured AAA with fusiform dilatation. This document does not cover patients …

Abdominal aortic aneurysm—2003: What we know, what we don't know—A review

PM Sanfelippo - International Journal of Angiology, 2003 - thieme-connect.com
Abdominal aortic aneurysm is a significant cause of morbidity and mortality. Although
descriptions of aneurysmal disease date back to 2000 BC, scientific approaches to …

Pathogenesis and management of abdominal aortic aneurysm

J Golledge, S Thanigaimani, JT Powell… - European Heart …, 2023 - academic.oup.com
Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …